BeatO Diabetes Care Program Reduced HbA1c by more than 2% points in 3 months – Clinical Study Reveals
New Delhi, 31st August 2023: In an effort to reduce complications and average HbA1c levels for people with diabetes, BeatO, a comprehensive digital platform for controlling and managing diabetes studied the impact of its proprietary Diabetes Care Program. This program has been subjected to clinical studies and its results were accepted by the top medical international journal and published in Diabetes, a journal of the American Diabetes Association® (ADA) in June 2023. The study showed a reduction of 2.16% (p < 0.0001) of HbA1c (average blood glucose level for the last 3 months) in the people with diabetes who participated in the study.
The results generated by the Diabetes Care Program by BeatO became more important in present times when the average HbA1c levels of people with dia...









